EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications

Ruiyin Guo, Gang Guo, Aili Wang iD, Gaochi Xu, Ren Lai iD, Hui Jin

Molecules · 20.12.2023 · 29 (1) · 35

DOI: 10.3390/molecules29010035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 20.12.2023. Verfasst von Ruiyin Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China. Hauptthemen laut MEDLINE: Biomedical Research, Spider Venoms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PI Project of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), 2023 Special Fund for Natural Resource Affairs (Ecological Forestry Construction), Shenzhen New Cornerstone Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spiders (Araneae), having thrived for over 300 million years, exhibit remarkable diversity, with 47,000 described species and an estimated 150,000 species in existence. Evolving with intricate venom, spiders are nature’s skilled predators. While only a small fraction of spiders pose a threat to humans, their venoms contain complex compounds, holding promise as drug leads. Spider venoms primarily serve to immobilize prey, achieved through neurotoxins targeting ion channels. Peptides constitute a major part of these venoms, displaying diverse pharmacological activities, and making them appealing for drug development. Moreover, spider-venom peptides have emerged as valuable tools for exploring human disease mechanisms. This review focuses on the roles of spider-venom peptides in spider survival strategies and their dual significance as pharmaceutical research tools. By integrating recent discoveries, it provides a comprehensive overview of these peptides, their targets, bioactivities, and their relevance in spider survival and medical research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomedical ResearchSpider VenomsHumansDrug DevelopmentNeurotoxinsPeptides

Stichwörter der Autor:innen

bioactivityspider-venom peptidesstructuresurvival strategytherapeutics

Substanzen

NeurotoxinsPeptidesSpider Venoms

Autor:innen und Institutionen

  • Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou 511458, China.
  • The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming 650118, China.
  • Key Laboratory of Bioactive Peptides of Yunnan Province, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, National Resource Center for Non-Human Primates, Kunming-Primate Research Cen…

ORCID-Profile: Aili Wang, Ren Lai

Förderung

  • PI Project of Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)
  • 2023 Special Fund for Natural Resource Affairs (Ecological Forestry Construction)
  • Shenzhen New Cornerstone Science Foundation
  • Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)

Zitieren

APA

Guo, R., Guo, G., Wang, A., Xu, G., Lai, R., & Jin, H. (2023). Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications. Molecules, 29(1), 35. https://doi.org/10.3390/molecules29010035

Vancouver

Guo R, Guo G, Wang A, Xu G, Lai R, Jin H. Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications. Molecules. 2023;29(1):35. doi:10.3390/molecules29010035

BibTeX
@article{Guo2023,
  author = {Guo, Ruiyin and Guo, Gang and Wang, Aili and Xu, Gaochi and Lai, Ren and Jin, Hui},
  title = {Spider-Venom Peptides: Structure, Bioactivity, Strategy, and Research Applications},
  journal = {Molecules},
  year = {2023},
  volume = {29},
  number = {1},
  pages = {35},
  doi = {10.3390/molecules29010035}
}
Kostenlos starten →